|
Volumn 12, Issue 2, 2002, Pages 113-116
|
Therapeutic possibilities in muscular dystrophy: The hope versus the hype
|
Author keywords
Cell therapy; Duchenne; Gene therapy; Muscular dystrophy; Protein upregulation; Therapy
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
DNA;
DYSTROPHIN;
GENTAMICIN;
PROTEIN;
UTROPHIN;
VIRUS VECTOR;
BICEPS BRACHII MUSCLE;
BONE MARROW CELL;
CELL CULTURE;
CELL DEATH;
CELL MIGRATION;
CELL TRANSFER;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE MODEL;
DUCHENNE MUSCULAR DYSTROPHY;
GENE DELETION;
GENE THERAPY;
HUMAN;
LIMB GIRDLE MUSCULAR DYSTROPHY;
MOLECULAR GENETICS;
MUSCLE ATROPHY;
MUSCLE STRENGTH;
MYOBLAST;
NOMENCLATURE;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SEPTICEMIA;
STOP CODON;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ANIMALS;
DISEASE MODELS, ANIMAL;
HUMANS;
MUSCULAR DYSTROPHIES;
MUSCULAR DYSTROPHY, ANIMAL;
RESEARCH DESIGN;
|
EID: 0036133504
PISSN: 09608966
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-8966(01)00319-4 Document Type: Conference Paper |
Times cited : (18)
|
References (22)
|